BUSINESS● LOWAug 5 · Aug 5, 2026, 8:31 PM
Zevra Therapeutics, Inc. GAAP EPS of $0.14 beats by $0.03, revenue of $39.7M beats by $5.82M
Seeking Alpha Tech
Zevra Therapeutics, Inc. reported earnings per share and revenue for the quarter that exceeded expectations. This indicates a positive financial performance for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoMercantile Bank Non-GAAP EPS of $1.42 beats by $0.07, revenue of $73.2M beats by $2.36MSeeking Alpha TechBUSINESS39m agoMaersk, Hateco sign deal for $3.5B rail terminal network in northern VietnamSeeking Alpha Tech